Market revenue in 2020 | USD 2,981.0 million |
Market revenue in 2028 | USD 5,210.8 million |
Growth rate | 7.2% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data covered | 2016 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Software & Services |
Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.65% in 2020. Horizon Databook has segmented the North America chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
North America dominated the global market in 2020, which can be attributed to rise in the demand for diagnostics due to increase in the incidence of chronic diseases and easy availability of technologically advanced diagnostic techniques.
In addition, high incidence of infectious diseases in the region, such as COVID-19, HIV, tuberculosis, and influenza, is boosting the demand for detection & treatment. Furthermore, well-established healthcare infrastructure and availability of government funding for research are anticipated to augment growth of the market in this region.
In July 2020, NIH invested USD 248.7 million in the development of new technologies in order to address challenges that are associated with testing of COVID-19. NIH’s Rapid Acceleration of Diagnostics (RADx)
Horizon Databook provides a detailed overview of continent-level data and insights on the North America chemiluminescence immunoassay market , including forecasts for subscribers. This continent databook contains high-level insights into North America chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account